CIK 0001701541 · Non-accelerated filer<br>Smaller reporting company
Black Diamond Therapeutics, Inc.
Sign in to watch- Ticker
- BDTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 814254660
- Phone
- 617-417-5868
- Business address
- 245 FIRST STREET, 18TH FLOOR, CAMBRIDGE, MA, 02142
- Former names
- Aset Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-18 | Raman Prakash Director | Grant or award | +6,801 | $1.93 | $13K | 51,840 |
| 2026-09-18 | Behbahani Ali Director | Grant or award | +7,707 | $1.93 | $15K | 110,236 |
| 2026-06-26 | Campbell Shannon Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-06-26 | Raman Prakash Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-06-26 | Kulkarni Samarth Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-06-26 | Menzel Garry E Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-06-26 | Dhingra Kapil Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-06-26 | Behbahani Ali Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-06-19 | Raman Prakash Director | Grant or award | +7,907 | $1.66 | $13K | 45,039 |
| 2026-06-19 | Behbahani Ali Director | Grant or award | +8,961 | $1.66 | $15K | 102,529 |
| 2026-03-20 | Raman Prakash Director | Grant or award | +6,105 | $2.15 | $13K | 37,132 |
| 2026-03-20 | Behbahani Ali Director | Grant or award | +6,919 | $2.15 | $15K | 93,568 |
| 2026-01-21 | Jones Erika SEE REMARKS | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2026-01-21 | Buck Elizabeth CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2026-01-21 | Velleca Mark A. PRESIDENT & CEO | Grant or award · Stock Option (Right to Buy) | +600,000 | 600,000 | ||
| 2026-01-21 | Yurasov Sergey CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2026-01-21 | Hatzis-Schoch Brent SEE REMARKS | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2025-12-12 | Raman Prakash Director | Grant or award | +4,665 | $2.76 | $13K | 31,027 |
| 2025-12-12 | Behbahani Ali Director | Grant or award | +5,208 | $2.76 | $14K | 86,649 |
| 2025-09-19 | Raman Prakash Director | Grant or award | +3,843 | $3.35 | $13K | 26,362 |
Page 1 of 6 · 114 trades